Looking into the Eyes of Patients with Antiphospholipid Syndrome

Overview

Journal Clin Rev Allergy Immunol

Specialty Allergy & Immunology

Date 2007 Oct 6

PMID 17916993

Citations 7

Authors

D Yehudai

Y Shoenfeld

E Toubi

Affiliations

Soon will be listed here.

Abstract

Diagnosis of antiphospholipid syndrome (APS) should be considered in all patients with recurrent systemic or ocular thrombosis in the absence of known risk factors. Because of the frequent ocular involvement in APS patients (as many as 80%), an ophthalmologic assessment should become a routine part of the clinical work-up of all patients in whom APS is highly suspected. The presence of isolated ocular thrombosis with persistently increased titers of antiphospholipid antibodies should be considered as definite APS. Ocular involvement in APS is frequently associated with other manifestations of the central nervous system (CNS), such as transient ischemic attack or cerebral vascular events. Diagnostic tools are needed to better establish a diagnosis of retinal vascular thrombosis. The treatment of isolated ocular APS should be based on the same principles as in all patients with systemic APS. Anticoagulation is aimed to prevent recurrent ocular or cerebral thromboses.

Citing Articles

Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations.

Gaspar P, Sciascia S, Tektonidou M Rheumatology (Oxford). 2024; 63(SI):SI24-SI36.

PMID: 38320589 PMC: 10846913. DOI: 10.1093/rheumatology/kead571.

Ocular Manifestations in Colombian Patients with Systemic Rheumatologic Diseases.

Uribe-Reina P, Munoz-Ortiz J, Cifuentes-Gonzalez C, Reyes-Guanes J, Terreros-Dorado J, Zambrano-Romero W Clin Ophthalmol. 2021; 15:2787-2802.

PMID: 34234401 PMC: 8254180. DOI: 10.2147/OPTH.S306621.

Ischemic retinal vasculitis and its management.

Talat L, Lightman S, Tomkins-Netzer O J Ophthalmol. 2014; 2014:197675.

PMID: 24839552 PMC: 4009272. DOI: 10.1155/2014/197675.

Analysis of clinical features of ocular presentation in cranial venous sinus thrombosis.

Wang D, Fang B, Wei S Eur J Med Res. 2011; 16(7):324-7.

PMID: 21813373 PMC: 3352004. DOI: 10.1186/2047-783x-16-7-324.

[Antiphospholipid syndrome and retinal vein occlusion. Meta-analysis of Published Studies].

Rehak M, Muller M, Scholz M, Wiercinska J, Niederwieser D, Wiedemann P Ophthalmologe. 2008; 106(5):427-34.

PMID: 18688615 DOI: 10.1007/s00347-008-1811-2.

References

Demirci F, Kucukkaya R, Akarcay K, Kir N, Atamer T, Demirci H . Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS. Int Ophthalmol. 2000; 22(6):323-9. DOI: 10.1023/a:1006305705080. View

Larsson J, Bauer B, Andreasson S . Fluorescein angiography versus ERG for predicting the prognosis in central retinal vein occlusion. Acta Ophthalmol Scand. 1998; 76(4):456-60. DOI: 10.1034/j.1600-0420.1998.760412.x. View

Maar N, Luksch A, Graebe A, Ergun E, Wimpissinger B, Tittl M . Effect of laser photocoagulation on the retinal vessel diameter in branch and macular vein occlusion. Arch Ophthalmol. 2004; 122(7):987-91. DOI: 10.1001/archopht.122.7.987. View

Greven C, SLUSHER M, Weaver R . Retinal arterial occlusions in young adults. Am J Ophthalmol. 1995; 120(6):776-83. DOI: 10.1016/s0002-9394(14)72731-x. View

Castanon C, Amigo M, Banales J, Nava A, Reyes P . Ocular vaso-occlusive disease in primary antiphospholipid syndrome. Ophthalmology. 1995; 102(2):256-62. DOI: 10.1016/s0161-6420(95)31028-7. View

Browning D, Fraser C . Retinal vein occlusions in patients taking warfarin. Ophthalmology. 2004; 111(6):1196-200. DOI: 10.1016/j.ophtha.2003.09.047. View

Kent D, Hickey-Dwyer M, Clark D . Long-term follow-up of ischaemic retinopathy in the antiphospholipid syndrome with lupus-like disease. Eye (Lond). 2000; 14 ( Pt 3A):313-7. DOI: 10.1038/eye.2000.79. View

Bashshur Z, Taher A, Masri A, Najjar D, Arayssi T, Noureddin B . Anticardiolipin antibodies in patients with retinal vein occlusion and no risk factors: a prospective study. Retina. 2003; 23(4):486-90. DOI: 10.1097/00006982-200308000-00007. View

Durrani O, Gordon C, Murray P . Primary anti-phospholipid antibody syndrome (APS): current concepts. Surv Ophthalmol. 2002; 47(3):215-38. DOI: 10.1016/s0039-6257(02)00289-8. View

10.

Gelfand Y, Dori D, Miller B, Brenner B . Visual disturbances and pathologic ocular findings in primary antiphospholipid syndrome. Ophthalmology. 1999; 106(8):1537-40. DOI: 10.1016/S0161-6420(99)90450-5. View

11.

Shoenfeld Y . Systemic antiphospholipid syndrome. Lupus. 2003; 12(7):497-8. DOI: 10.1191/0961203303lu396xx. View

12.

Mruthyunjaya P, Wirostko W, Chandrashekhar R, Stinnett S, Lai J, Deramo V . Central retinal vein occlusion in patients treated with long-term warfarin sodium (Coumadin) for anticoagulation. Retina. 2006; 26(3):285-91. DOI: 10.1097/00006982-200603000-00006. View

13.

Giorgi D, David V, Afeltra A, Gabrieli C . Transient visual symptoms in systemic lupus erythematosus and antiphospholipid syndrome. Ocul Immunol Inflamm. 2001; 9(1):49-57. DOI: 10.1076/ocii.9.1.49.3980. View

14.

Cekic O, Chang S, Tseng J, Barile G, Del Priore L, Weissman H . Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2005; 25(7):851-5. DOI: 10.1097/00006982-200510000-00006. View

15.

Asherson R, Merry P, Acheson J, Harris E, Hughes G . Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Ann Rheum Dis. 1989; 48(5):358-61. PMC: 1003763. DOI: 10.1136/ard.48.5.358. View

16.

Hvarfner C, Andreasson S, Larsson J . Multifocal electroretinography and fluorescein angiography in retinal vein occlusion. Retina. 2006; 26(3):292-6. DOI: 10.1097/00006982-200603000-00007. View

17.

Incorvaia C, Bandello F, Parmeggiani F, DAngelo S, Costagliola C, Sebastiani A . Recurrent central retinal vein occlusion in a young thrombophilic patient with factor V Leiden mutation. Eur J Ophthalmol. 2002; 12(2):131-4. View

18.

Kalogeropoulos C, Spyrou P, Stefaniotou M, Tsironi E, Drosos A, Psilas K . Anticardiolipin antibodies and occlusive vascular disease of the eye: prospective study. Doc Ophthalmol. 1999; 95(2):109-20. DOI: 10.1023/a:1001131323739. View

19.

Arsene S, Giraudeau B, Le Lez M, Pisella P, Pourcelot L, Tranquart F . Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year. Br J Ophthalmol. 2002; 86(11):1243-7. PMC: 1771351. DOI: 10.1136/bjo.86.11.1243. View

20.

Giorgi D, Pace F, Giorgi A, BONOMO L, Gabrieli C . Retinopathy in systemic lupus erythematosus: pathogenesis and approach to therapy. Hum Immunol. 1999; 60(8):688-96. DOI: 10.1016/s0198-8859(99)00035-x. View